Literature DB >> 11599309

Neuroactive steroids and central nervous system disorders.

M Wang1, T Bäckström, I Sundström, G Wahlström, T Olsson, D Zhu, I M Johansson, I Björn, M Bixo.   

Abstract

Steroid hormones are vital for the cell life and affect a number of neuroendocrine and behavioral functions. In contrast to their endocrine actions, certain steroids have been shown to rapidly alter brain excitability and to produce behavioral effects within seconds to minutes. In this article we direct attention to this issue of neuroactive steroids by outlining several aspects of current interest in the field of steroid research. Recent advances in the neurobiology of neuroactive are described along with the impact of advances on drug design for central nervous system (CNS) disorders provoked by neuroactive steriods. The theme was selected in association with the clinical aspects and therapeutical potentials of the neuroactive steroids in CNS disorders. A wide range of topics relating to the neuroactive steroids are outlined, including steroid concentrations in the brain, premenstrual syndrome, estrogen and Alzheimer's disease, side effects of oral contraceptives, mental disorder in menopause, hormone replacement therapy, Catamenial epilepsy, and neuractive steroids in epilepsy treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11599309     DOI: 10.1016/s0074-7742(01)46071-5

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  9 in total

Review 1.  Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders.

Authors:  Anna-Carin N-Wihlbäck; Inger Sundström-Poromaa; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2005-12-15       Impact factor: 4.530

2.  The interaction between ethanol and pregnanolone at induction of anaesthesia investigated with a threshold method in male rats.

Authors:  M D Wang; D Zhu; T Bäckström; G Wahlström
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 3.  The role of hormones and hormonal treatments in premenstrual syndrome.

Authors:  Torbjörn Bäckström; Lotta Andreen; Vita Birzniece; Inger Björn; Inga-Maj Johansson; Maud Nordenstam-Haghjo; Sigrid Nyberg; Inger Sundström-Poromaa; Göran Wahlström; Mingde Wang; Di Zhu
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 4.  Different Prognostic Patterns in Epilepsies and Considerations About the Denotations of Atypical Patterns.

Authors:  Arife Çimen Atalar; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2022-01-31       Impact factor: 1.339

5.  Epibrassinolide prevents tau hyperphosphorylation via GSK3β inhibition in vitro and improves Caenorhabditis elegans lifespan and motor deficits in combination with roscovitine.

Authors:  Pinar Obakan Yerlikaya; Elif Damla Arısan; Ajda Coker Gurkan; Osman Orcun Okumus; Tugba Yenigun; Utku Ozbey; Melissa Kara; Narcin Palavan Unsal
Journal:  Amino Acids       Date:  2021-08-13       Impact factor: 3.520

6.  Effects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor.

Authors:  Cheryl A Frye; J J Paris; A A Walf; J C Rusconi
Journal:  Front Neurosci       Date:  2012-01-19       Impact factor: 4.677

7.  Neurosteroids and GABA-A Receptor Function.

Authors:  Mingde Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-04       Impact factor: 5.555

Review 8.  Steroid Sulfation in Neurodegenerative Diseases.

Authors:  Jana Vitku; Martin Hill; Lucie Kolatorova; Eva Kubala Havrdova; Radmila Kancheva
Journal:  Front Mol Biosci       Date:  2022-02-23

9.  Development and validation of a predictive model of drug-resistant genetic generalized epilepsy.

Authors:  Hyunmi Choi; Kamil Detyniecki; Carl Bazil; Suzanne Thornton; Peter Crosta; Hatem Tolba; Manahil Muneeb; Lawrence J Hirsch; Erin L Heinzen; Arjune Sen; Chantal Depondt; Piero Perucca; Gary A Heiman
Journal:  Neurology       Date:  2020-08-05       Impact factor: 9.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.